Detalhe da pesquisa
1.
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Open Forum Infect Dis
; 10(5): ofad211, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229174